Applied DNA Sciences (NASDAQ:APDN) is scheduled to be posting its quarterly earnings results after the market closes on Thursday, May 9th.
Applied DNA Sciences (NASDAQ:APDN) last released its quarterly earnings data on Thursday, February 7th. The technology company reported ($0.11) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.08) by ($0.03). Applied DNA Sciences had a negative net margin of 283.98% and a negative return on equity of 458.79%. The business had revenue of $0.88 million during the quarter.
APDN opened at $0.65 on Tuesday. Applied DNA Sciences has a 12-month low of $0.30 and a 12-month high of $1.84. The company has a quick ratio of 1.60, a current ratio of 1.68 and a debt-to-equity ratio of 2.82.
Applied DNA Sciences Company Profile
Applied DNA Sciences, Inc develops and markets plat based or other DNA technology solution in the United States, Europe, and Asia. The company's supply chain security and product authentication solutions include SigNature molecular tags that are ingredients used to fortify brand protection efforts and strengthen supply chain security, as well as mark, track, and convict criminals; SigNature T molecular tags, which are tagging and authentication systems for use in brand protection efforts and raw material source compliance programs; and fiberTyping, a test of native cotton fiber DNA.
Further Reading: Marijuana Stocks Future Looks Bright
Receive News & Ratings for Applied DNA Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Applied DNA Sciences and related companies with MarketBeat.com's FREE daily email newsletter.